Antihemophilic Factor/von Willebrand Factor Complex (Human), Dried, Pasteurized.
出版信息
P T. 2010 Jan;35(1 Section 2):2-24.
Abstract
摘要
相似文献
1
Antihemophilic Factor/von Willebrand Factor Complex (Human), Dried, Pasteurized.抗血友病因子/血管性血友病因子复合物（人源），冻干，经巴氏杀菌处理
P T. 2010 Jan;35(1 Section 2):2-24.
2
Partial purification of biologically active, low molecular weight, human antihemophilic factor free of Von Willebrand factor. I. Partial characterization and evidence for disulfide bond(s) susceptible to limited reduction.不含血管性血友病因子的具有生物活性的低分子量人抗血友病因子的部分纯化。I. 部分特性鉴定及对有限还原敏感的二硫键的证据
Biochim Biophys Acta. 1981 May 29;668(3):456-70. doi: 10.1016/0005-2795(81)90180-x.
3
Macromolecular factor VIII complex: functional and structural heterogeneity observed in von Willebrand swine with transfusion.大分子因子VIII复合物：在输血的血管性血友病猪中观察到的功能和结构异质性。
Proc Natl Acad Sci U S A. 1977 Feb;74(2):759-63. doi: 10.1073/pnas.74.2.759.
4
In Vitro Assessment of von Willebrand Factor in Cryoprecipitate, Antihemophilic Factor/VWF Complex (Human), and Recombinant von Willebrand Factor.在体外评估冷沉淀中的血管性血友病因子、抗血友病因子/血管性血友病因子复合物（人）和重组血管性血友病因子。
Clin Appl Thromb Hemost. 2019 Jan-Dec;25:1076029619873976. doi: 10.1177/1076029619873976.
5
Partial purification of biologically active, low molecular weight, human antihemophilic factor free of Von Willebrand factor. II. Further purification with thiol-disulfide interchange chromatography and additional evidence for disulfide bonds susceptible to limited reduction.不含血管性血友病因子的生物活性低分子量人抗血友病因子的部分纯化。II. 用硫醇-二硫键交换色谱法进一步纯化及二硫键易受有限还原影响的更多证据
Biochim Biophys Acta. 1981 May 29;668(3):471-80. doi: 10.1016/0005-2795(81)90181-1.
6
Nature of von Willebrand factor: a new assay and a specific inhibitor.血管性血友病因子的性质：一种新检测方法和一种特异性抑制剂。
Proc Natl Acad Sci U S A. 1974 Aug;71(8):2937-41. doi: 10.1073/pnas.71.8.2937.
7
Plasma aggregating factor (bovine) for human platelets: a marker for study of antihemophilic and von Willebrand Factors.人血小板的血浆聚集因子（牛源）：一种用于研究抗血友病因子和血管性血友病因子的标志物。
Proc Natl Acad Sci U S A. 1973 Oct;70(10):2814-8. doi: 10.1073/pnas.70.10.2814.
8
9
Von Willebrand factor: dissociation from antihemophilic factor procoagulant activity.血管性血友病因子：与抗血友病因子促凝活性的解离
Science. 1973 Dec 14;182(4117):1149-51. doi: 10.1126/science.182.4117.1149.
10
Von Willebrand factor: gene dosage relationships and transfusion response in bleeder swine--a new bioassay.血管性血友病因子：出血性猪的基因剂量关系与输血反应——一种新的生物测定法
Proc Natl Acad Sci U S A. 1974 May;71(5):2087-90. doi: 10.1073/pnas.71.5.2087.
本文引用的文献
1
Von Willebrand disease: screening, diagnosis, and management.血管性血友病：筛查、诊断与管理
Aesthet Surg J. 2008 Mar-Apr;28(2):189-94. doi: 10.1016/j.asj.2007.12.002.
2
Evidence-based diagnosis of type 1 von Willebrand disease: a Bayes theorem approach.1型血管性血友病的循证诊断：贝叶斯定理方法
Blood. 2008 Apr 15;111(8):3998-4003. doi: 10.1182/blood-2007-08-105940. Epub 2008 Jan 10.
3
Management of inherited von Willebrand disease in 2007.2007年遗传性血管性血友病的管理
Ann Med. 2007;39(5):346-58. doi: 10.1080/07853890701513738.
4
The mutational spectrum of type 1 von Willebrand disease: Results from a Canadian cohort study.1型血管性血友病的突变谱：一项加拿大队列研究的结果。
Blood. 2007 Jan 1;109(1):145-54. doi: 10.1182/blood-2006-05-021105..
5
Advances in the diagnosis and management of von Willebrand disease.血管性血友病诊断与治疗的进展
Hematology. 2006 Aug;11(4):219-25. doi: 10.1080/10245330600841311.
6
Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD).在欧洲开展的“1型血管性血友病诊断与管理的分子和临床标志物研究（MCMDM-1VWD）”中，一组历史上被诊断为1型血管性血友病的家族的表型和基因型。
Blood. 2007 Jan 1;109(1):112-21. doi: 10.1182/blood-2006-05-020784. Epub 2006 Sep 19.
7
Diagnosis of inherited von Willebrand disease: a clinical perspective.遗传性血管性血友病的诊断：临床视角
Semin Thromb Hemost. 2006 Sep;32(6):555-65. doi: 10.1055/s-2006-949661.
8
Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor.血管性血友病的病理生理学与分类更新：血管性血友病因子小组委员会报告
J Thromb Haemost. 2006 Oct;4(10):2103-14. doi: 10.1111/j.1538-7836.2006.02146.x. Epub 2006 Aug 2.
9
Treatment of von Willebrand's Disease.血管性血友病的治疗
N Engl J Med. 2004 Aug 12;351(7):683-94. doi: 10.1056/NEJMra040403.
10
Bleeding prophylaxis for major surgery in patients with type 2 von Willebrand disease with an intermediate purity factor VIII-von Willebrand factor concentrate (Haemate-P).使用中间纯度的凝血因子VIII-血管性血友病因子浓缩物（海莫莱士）对2型血管性血友病患者进行大手术时的出血预防。
Blood Coagul Fibrinolysis. 2004 Jun;15(4):323-30. doi: 10.1097/00001721-200406000-00006.
Zotero 插件